Manufacturer record

Ashish Lifesciences Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Ashish Lifesciences Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between November 2021 and November 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Ashish Lifesciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2021 to Nov 2021

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2021
1
Products affected
Other
Most common failure
Nov 2021
Latest alert

Flagged batches per year

2021 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ashialben 600 (Albendazole Bolus 600 mg) ALT-8703Mfg 2020-12 · Exp 2024-11 Moisture contentOther CDTL MumbaiCDSCO lab Nov 2021
Ashialben 300 (Albendazole 300 mg Bolus) ALT-9096Mfg 2021-08 · Exp 2025-07 Moisture contentOther CDTL MumbaiCDSCO lab Nov 2021
Ashialben 300 (Albendazole 300 mg Bolus) ALT-8958Mfg 2021-05 · Exp 2025-04 Moisture contentOther CDTL MumbaiCDSCO lab Nov 2021
Ashialben 300 (Albendazole 300 mg Bolus) ALT-9090Mfg 2021-08 · Exp 2025-07 Moisture contentOther CDTL MumbaiCDSCO lab Nov 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.